Abstract
Background Acute ingestion of alcohol impairs cognitive function and poses significant threat to public health and safety with impaired operation of motor vehicles. However, there is a lack of access to tools to assess one’s cognitive impairment due to alcohol. The purpose of this study was to explore the use of a neuropsychological assessment software, BrainCheck, to assess levels of alcohol impairment based on performance on the neuropsychological assessments.
Methods The BrainCheck battery was administered to 91 volunteer participants. Participants were required to take a baseline battery prior to any alcohol ingestion, and another testing battery after a voluntary drinking period. Blood alcohol content (BAC) for the participants was obtained using a breathalyzer. Participant assessments were grouped into an intoxicated group with BAC > 0.05, and a sober group with BAC ≤ 0.05. Statistical analysis comparing intoxicated vs sober performance on the BrainCheck battery was performed. Significant metrics deemed by relative t-test and correlations with BAC were used to build statistical learning models to predict participant BAC and classify intoxicated vs. sober.
Results Relative t-tests found two assessment metrics to be significant among comparison groups after P-value correction. Four test metrics were observed to moderately correlate (|r| > 0.40) with BAC levels. Three linear regression models (least-squares, ridge and LASSO) were built to predict participant BAC levels, with the best performing model being the least-squares model with a RMSE of 0.027, compared to the baseline RMSE of 0.061. Logistic regression models were built to classify whether the participant was intoxicated or not, with the best model performing at 80.6% accuracy, 73.3% sensitivity, and 75.0% specificity.
Discussion The BrainCheck battery has potential to predict alcohol impairment, including participant BAC levels and if the participant is intoxicated or not. BrainCheck provides another option to assess an individual’s cognitive impairment due to alcohol, with the utility of being portable and available on one’s smartphone.
Competing Interest Statement
The following authors declare the following competing interests: BF, YK, BH, RHG reports personal fees from BrainCheck, outside the submitted work; DME, BF, YK, BH, RHG reports receiving stock options from BrainCheck.
Funding Statement
Funding was provided by BrainCheck, Inc.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study protocol was reviewed and approved by Solutions IRB. All participants were required to sign for informed consent to be in the study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data may be made available by contacting the corresponding author and with a data use agreement.
